Business ❯Pharmaceutical Industry

Corporate Ethics

Profit from Medical Research Profit from Research Price Manipulation Regulatory Compliance Health Regulations

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

The settlement resolves claims that Biohaven, acquired by Pfizer in 2022, used improper financial incentives to boost prescriptions of Nurtec ODT.

Henrietta Lacks' Family Files Lawsuit Against Novartis and Viatris Over HeLa Cell Use